Medicine and Dentistry
Congenital Hyperinsulinism
100%
Infancy
55%
Adenosine Triphosphate Sensitive Potassium Channel
36%
Hypoglycemia
34%
Diseases
32%
Adenosine Triphosphate
31%
Hyperinsulinism
26%
Insulin Release
24%
Pancreatectomy
15%
Cell Line
14%
Diazoxide
14%
Human Insulin
14%
Hyperinsulinemic Hypoglycemia
14%
Recombinant Human Insulin
14%
Clinical Management
13%
Pancreatic Islet
13%
In Vitro
10%
Stem Cell
10%
Potassium Channel
9%
Human Embryonic Stem Cell
9%
Metabolomics
9%
Kir6.2
9%
Sulfonylurea Receptor 1
9%
Mosaicism
8%
Gene Mutation
8%
Somatostatin Cell
8%
Pathophysiology
7%
Rare Disease
7%
Ion Channel
6%
Combination Therapy
6%
Adenoma
6%
Feeding Difficulty
6%
Endocrine Disease
6%
Beckwith Wiedemann Syndrome
6%
Cell Lineage
6%
Usher Syndrome
6%
Cell Damage
6%
Cell Transplantation
6%
Muscle Tissue
6%
Chromosome 11p
6%
Smooth Muscle
6%
Cell Cycle Regulation
6%
Diabetes
5%
Absence
5%
Transcription Factors
5%
Drug Therapy
5%
Patch Clamp
5%
Potassium Ion
5%
Biochemistry, Genetics and Molecular Biology
Congenital Hyperinsulinism
51%
Infancy
50%
Adenosine Triphosphate
36%
Insulin Release
29%
ATP-Sensitive Potassium Channel
26%
Potassium Channel
22%
Sulfonylurea Receptor
13%
ABCC8
13%
Metabolomics
12%
Kir6.2
9%
Transcription Factors
9%
Mosaicism
8%
Transcription Factor PDX 1
8%
PAX4
8%
Somatostatin Cell
8%
ATP-sensitive Potassium Channel
7%
Stimulus Secretion Coupling
7%
Beckwith-Wiedemann Syndrome
6%
Independent Pathway
6%
Gene Deletion
6%
Metabolite
6%
Proteomics
6%
Embryonic Stem Cell
6%
Pharmacogenomics
6%
Interactome
6%
Cellular Differentiation
6%
Small Molecule
6%
Cell Metabolism
5%
Anaplerosis
5%
